abs174.txt	rna	sequencing	(rna-seq)	detects	estrogen	receptor	alpha	gene	(esr1)	fusiontranscripts	in	receptor-positive	(er+)	breast	cancer		but	their	role	indisease	pathogenesis	remains	unclear	we	examined	multiple	esr1	fusions	and	foundthat	two	both	identified	advanced	endocrine	treatment-resistant	disease	encoded	stable	functional	fusion	proteins	examples	esr1-e6>yap1	andesr1-e6>pcdh11x	exons	1-6	were	fused	frame	to	c-terminal	sequences	fromthe	partner	properties	include	estrogen-independent	growth	constitutive	expression	of	er	target	genes	anti-estrogen	resistance	bothfusions	activate	a	metastasis-associated	transcriptional	program	induce	cellularmotility	promote	the	development	lung	metastasis	esr1-e6>yap1-	andesr1-e6>pcdh11x-induced	remained	sensitive	cdk4/6	inhibitor	apatient-derived	xenograft	(pdx)	naturally	expressing	wasalso	responsive	transcriptionally	active	therefore	trigger	bothendocrine	therapy	metastatic	progression	explaining	theassociation	with	fatal	although	treatmentis	predicted	be	effective
